The integration of additive manufacturing (AM) technology within biological systems holds significant potential, specifically when refining the methods utilised for the creation of in vitro models.
Introduction
The possibility of three-dimensional (3D) printing (also known as Additive Manufacturing) bespoke biologically receptive parts, has driven the increasing application of Additive Manufacture (AM) technologies in biological systems. Techniques such as Fused Deposition Modelling (FDM), [1] photopolymerisation processes such as stereolithography (SL) [2, 3] and PolyJet printing, in addition to powder-based particle consolidation laser sintering (LS) [4] technology have all previously been utilised to provide devices/scaffolds for bioengineering. [5] [6] [7] [8] [9] [10] [11] However, the numerous advantages of AM, including design freedom and rapid production without moulds or tooling, are currently offset by a lack of fully characterised biocompatible materials. [12, 13] FDM affords a variety of biocompatible polymers with the capability to control and influence cellular phenotype, [14] however such compatibility is, in part, negated when geometries with design features of increasing complexity are required. Despite being the most widely used, inexpensive and readily available 3D printing process, the diverse application of AM across scientific disciplines has elicited a trend toward the commercialisation of alternative processes capable of manufacturing such advanced geometries. SL and jetting based printing afford the capability to produce sophisticated designs, however the chemical complexity of the photo-sensitive resins typically result in non-biocompatible parts. [15] These devices typically require time-consuming polymer surface modification in order to facilitate cellular compatibility. [16] Comparable design complexities are attainable when printing with LS, however the accessibility of such technology has previously been commercially limited. Despite recent developments in the commercialisation of 3D printing technology toward user-friendly desktop appliances, investigations detailing the biocompatibility of useable polymers remain scarce. As such, the development of a wide-ranging knowledge base of AM candidate polymers derived across a range of advanced 3D printing processes remains imperative. [17] Favourable candidate polymers for biological integration often require commercially available and accessible resins of transparent/clear appearance, to enable the visualisation of cellular samples within engineered devices. Polymers such as SL desktop appliance FormLabs TM Clear-FLGPCL02 resin and PolyJet VeroClear-RGD810 resin, which can form optically transparent structures, satisfy the criteria.
In addition, biologically amenable candidate Nylon-6 polymers [18] have previously been documented, outlining the applicability of LS polyamide-12 (PA-12) when fabricating biocompatible devices. [19] 3D printed biocompatible polymers hold significant importance for tissue and biochemical engineering applications, with the methods required to construct the models that examine highly complex cellular physiological processes currently being revolutionised by AM. [6, [20] [21] [22] [23] [24] [25] [26] [27] Pertinent to this are tissue engineered in vitro models, [28] [29] [30] [31] designed to replicate the in vivo cellular and molecular mechanisms that regulate musculoskeletal [32] and neuromuscular disorders. [33] As such, defining the compatibility of mammalian cells frequently used within these models; C2C12 murine skeletal myoblasts [34] and SH-SY5Y neuroblastoma [35] human derived cell lines are of particular relevance. This is primarily due to the lack of availability of primary tissue, and their capability to afford physiologically representative in vitro models of native human in vivo tissues. Human derived HepG2 hepatocellular carcinoma [36] cell line also holds significant importance due to their use within pharmaceutical toxicity assessments. Cytochrome P450 enzymes are of specific interest within toxicology research, [37] [38] [39] due to their central role in drug metabolism [40] , outlining the necessity for their inclusion within this research.
Due to the diverse range of printed devices within biological systems, it is of paramount importance to comprehend both the indirect and direct effects of 3D printable polymers. As such, this investigation sought to determine the direct (cells cultured directly on the polymer) and indirect (cells cultured in chemical leached medium) effect of three commercially available 3D printable polymers across three sophisticated AM processes. SL: Clear FLGPCL02 (FormLabs GmbH), PolyJet: VeroClear-RGD810 (Stratasys) and LS: PA2200 (which is a polyamide-12 PA-12, EOS GmbH) on C2C12, SH-SY5Y and HepG2 cellular compatibility.
Materials and Methods

3D Printing and Sample Preparation
3D printing was undertaken utilising the following processes and parameters: FormLabs Form 2 TM machine using the clear resin FLGPCL02 set at 0.1 mm layer thickness. Stratasys Objet Connex 500 TM using the VeroClear-RGD810 material (with SUP705 support material) set at 0.33 mm layer thickness and default speed/quality settings. EOS Formiga P100 TM using EOS PA2200 powder (PA-12) at 0.1 mm layer thickness. 3D CAD modelling was performed using Siemens NX software (v8.5, Siemens) with completed .stl files verified using Materialise MiniMagics (Materialise NV).
Completed .stl files were processed using manufacturer recommended software for each process.
Clear FLGPCL02 (Clear-FL) samples were removed from the build plate and cleaned in isopropanol to remove uncured resin, prior to being submersed and agitated in 70% industrial methylated spirit (IMS) for ≤ 30 mins. VeroClear-RGD810 (VeroClear) and PA-12 samples were removed from build plates and cleaned using a soft abrasive brush to remove supports and un-sintered powder respectively.
All samples were sterilised via UV for ≥ 1 h, prior to being adhered to culture well plates using an inhouse bio-adhesive (aquarium glue) that has been found to be biocompatible. [14] Once adhered, samples were rinsed with 70% IMS and left for remaining liquid to evaporate, prior to being further treated with 1x phosphate buffered saline (PBS). Prior to experimental treatment, Clear-FL and VeroClear samples (preconditioned by the same processing steps as the final intended product) were exposed to 10 days incubation within static growth medium (5 ml, supplementary material Figure. S1) at 37 ºC to facilitate the withdrawal of potentially harmful chemical leachate from sample scaffolds.
Each sample scaffold disc (30 mm Ø x 1 mm thick, surface area ~ 15cm 2 ) provided a 3cm 2 per ml surface area to volume ratio and was designed to cover most of the culture area of a six-well plate.
Where suitable, the methodology was devised with the international standards organisation (ISO 10993) guidelines taken into consideration (Table S1, supplementary material). 
Cell Culture
Experimental Treatments
Experiments were designed to simultaneously assess critical evidence of cellular viability, morphological observations and cell line specific phenotype characterisation, in response to the direct (cells cultured directly on the polymer) and indirect (cells cultured within chemical leachate) effects of each polymer. 3D printed samples were used to evaluate the direct (n=2) and indirect (n=2) biocompatibility of each polymer per repeat (n=3). Experiments generated n=6 per condition, totalling n=12 per analyses at each specific time-point, derived from n=3 experimental repeats. This protocol was completed separately for each cell line (C2C12, SH-SY5Y and HepG2).
To assess direct biocompatibility, 1 x 10 5 (C2C12, HepG2) or 1 x 10 4 (SH-SY5Y) cells were seeded either directly onto the 3D printed discs that had been adhered to wells and left for ≥ 1 h to allow for initial cellular adhesion, or to control (CON) wells. Once attached, 2 ml GM was added to each well.
To assess the indirect biocompatibility of chemical leachate from each polymer, 3D printed discs were attached to the culture area of two wells that were acellular, containing only medium (MEDIA ONLY). Chemically leached medium was then transferred to its corresponding experimental well during each repeat, ensuring that cellular medium was directly representative of either cumulative polymer degradation or CON at each specific time-point. Each MEDIA ONLY well was preincubated with 2 ml GM for 24 h prior to commencing each experiment, to ensure cells were seeded within media that had been exposed to the chemical leachate of each polymer. Medium, once transferred to experimental wells, was replenished for further 24 h incubation prior to each subsequent media change. During the last 24 h in which the cells were cultured in GM, DM was added to the MEDIA ONLY wells in preparation to induce differentiation in C2C12 and SH-SY5Y cell cultures.
Cells were analysed for cell viability at cell line specific time-points and fixed for fluorescence imaging at DM120 h (C2C12), DM72 h (SH-SY5Y) and GM96 h (HepG2) time-points. After concluding cellular viability analysis at experimental termination, cells were washed twice with 2 ml PBS, prior to RNA isolation with cells being immersed and homogenised in 0.5 ml TRIzol per well. Light micrographs were captured on a Leica DMIL LED Light Microscope. Fluorescence images were visualised using a Leica DM2500 fluorescence microscope (20x) with manufacturer's software (Leica Application Suite X). Images were analysed using IMAGE J 1.50a/Fiji (Java 1.6.0_24) software (National institute of Health, Bethesda, MD, USA). Image inclusion criteria were set at ≥ 5 images per well. Myotube inclusion criteria were defined as containing ≥ 3 nuclei per myotube.
Fluorescence Staining and Microscopy
Cumulative frequencies were calculated to determine the number of measures required per myotube, in addition to the number of myotubes and neurites necessitated per image for each analysis. Analysis of nuclei number was performed using an in-house macro instruction designed for Fiji (Java 1.6.0_24) image analysis software (Image J 1.50a).
Cell Viability alamarBlue® Assay
Cellular viability reagent; alamarBlue® diluted 1:10 DMEM (C2C12), Glutamax (SH-SY5Y) or MEM (HepG2) was used to assess cell viability and proliferation in C2C12 and SH-SY5Y at 72 and 120 h experimental time-points. HepG2 cells were analysed every 24 h across the 96 h culture period. Cells were washed twice with 2 ml PBS prior to being treated with 2 ml per well alamarBlue® stock solution and humidified 5 % CO2 at 37 °C for 4 h. 100 μl per well of solution was then added to a black well 96-well plate and analysed for fluorescence intensity. Increased fluorescence of alamarBlue® reagent is indicative of an increase in cellular viability. alamarBlue® fluorescence signal was excited at 540-570 nm (peak excitation: 570 nm) and emitted at 580-610 nm (peak emission: 585 nm).
RNA extraction and Quantitative RT-PCR
RNA was extracted using the TRIzol method, according to manufacturer's instructions (Sigma). RNA concentration and purity were obtained by UV spectroscopy at optical density (ODs) of 260 and 280 nm using a Nanodrop 2000 (Fisher, Rosklide, Denmark). All RNA samples were analysed in duplicate. Twenty nanograms of RNA were used per RT-PCR paired species-specific reaction for RPII-β and MYH3 (C2C12), two nanograms for RPII-β and MAPT (SH-SY5Y) and two nanograms for RPII-β, CYP1A1, 1A2, 2D6 and 3A4 (HepG2, Table 1 ). All mRNA expression of cells cultured within direct/indirect polymer conditions is normalised to that of control, hence responses above or below control values are indicative of increased or decreased gene transcription.
RT-PCR amplifications were carried out using Power SYBR Green RNA-to-CT 1 step kit (Qiagen) on a ViiA TM Real-Time PCR System (Applied bio-systems, Life Technologies), analysed using ViiA TM 7RUO Software. RT-PCR procedure was as follows: 50 °C, 10 min (for cDNA synthesis), 95 °C, 5 min (transcriptase inactivation), followed by 95 °C, 10 sec (denaturation), 60 °C, 30 sec (annealing/extension) for 40 cycles. Relative gene expression was calculated using the comparative CT (ΔΔCT) equation for normalised expression ratios; relative expression calculated as 2 -ΔΔCT , where CT is representative of the threshold cycle. [41] RPII-β was used as the housekeeping gene in all RT- 
Statistical analysis
Statistical analyses and significance of data were determined using IBM © SPSS © Statistics version 23.
Mauchly's test of sphericity and Shapiro-Wilk tests were used to confirm homogeneity of variance and normal distribution of data respectively. Where parametric assumptions were met, a 4 x 2 (SH-SY5Y & C2C12) and 4 x 4 (HepG2) ANOVA was used for alamarBlue® analyses. One-way ANOVA
(1 x 4) was used to analyse mRNA expression and morphological data; myotube number, myotube width, fusion index, nuclei number and neurite length only concerned with experimental termination time-points. Where significant interactions were observed, Bonferroni post-hoc analyses were used to analyse differences between conditions at specific time-points. Non-parametric Kruskal-Wallis (H) analysis was undertaken where data violated parametric assumptions. Mann-Whitney (U) tests were then utilised to determine significance between conditions, in accordance with Bonferroni correction to account for incremental type-1 error. All data is reported as mean ± standard deviation (SD).
Significance was assumed at P ≤ 0.05.
Results
C2C12
Cell Viability
Cellular viability of C2C12 skeletal myoblasts cultured on 3D printed polymer scaffolds was significantly impaired across all conditions after GM72 h ( Figure. 
C2C12 Morphology
C2C12 cells displayed significant morphological reductions in myotube number ( Figure. 
C2C12 MYH3 mRNA Expression
Significant decreases in MYH3 ( Figure. 3), the embryonic heavy chain predominantly expressed within two dimensional skeletal muscle cultures, [42] were documented in C2C12 cells cultured on 3D 
SH-SY5Y
Cell Viability
SH-SY5Y metabolic activity ( Figure. 
SH-SY5Y Morphology
Significantly potentiated neurite axonal extension ( Figure. 
SH-SY5Y MAPT mRNA Expression
HepG2
Cell Viability
HepG2 cells displayed diminished viability ( Figure. 
HepG2 Morphology
The metabolic activity of HepG2 cells cultured directly on polymer scaffolds demonstrated correlation with nuclear number (Figure. 
HepG2 Cytochrome P450 mRNA Expression
HepG2 cytochrome P450 CYP1A1 mRNA expression was significantly up regulated in Clear-FL (P = 0.006) and VeroClear (P = 0.017) direct polymer scaffold conditions ( Figure. 
Discussion
Understanding the cellular physiological interaction with the physical/physico-chemical properties of 3D printed polymers is of critical importance. Particularly when evaluating the specific AM process and polymer combination while creating physiologically representative in vitro models, [28] [29] [30] [31] that are utilised within tissue engineering and or pharmaceutical screening applications. This research demonstrates cell type specific biocompatibility across a range of industry standard 3D printing techniques; SL, LS and PolyJet, for incorporation within tissue engineering models of musculoskeletal [32] and neurological disorders, [33] in addition to pharmacological screening systems. [37] In this work we used C2C12, SH-SY5Y and HepG2 cell lines in order to ascertain critical evidence of cellular behaviour in response to 3D printed candidate polymers due to their capacity to afford a range of optically transparent (Clear-FL and VeroClear) and bio-inert (PA-12) parts from commercially available and accessible AM instrumentation.
Whilst the chemical compositions of these polymers (specifically Clear-FL and VeroClear) are often commercially protected proprietary material formulations, it is possible to determine the general characteristics of these materials. UV curable photo-polymers are typically based on acrylates, epoxides and urethanes with the final material likely to be densely crosslinked. [43] Specifically, the Clear-FL resin contains a proprietary mixture of methacrylate oligomers and monomers, as well as a photoinitiator. [44] VeroClear resin contains acrylic monomer (<30%), acrylic oligomer (<15%), isobornyl acrylate (<25%), photoinitiator (<2%) and acrylic acid ester (<0.3%). [45] The composition of both the uncured liquid resins and chemically leached components for both Clear-FL and VeroClear were assessed via Nuclear Magnetic Resonance spectroscopy (NMR, Figure. These lamps also have a wider spread of wavelengths emitted. In addition, in SL the scan strategy (pattern) described by the laser for each layer can be altered to improve accuracy and or speed. As such, the final solid state of SL printed parts will be dependent on a combination of the print settings (scan pattern, layer thickness, etc.), curing process, type of resin and specific machine. Data observed within NMR analyses indicated that compounds containing acrylate functionality (Clear-FL and VeroClear photo-polymers) appear to be the major component of leached compounds during the solvent extraction affecting the cell lines used. This indicates potentially incomplete crosslinking of monomer resin during the printing process. Adverse biological outputs upon the cell lines tested are likely a combination of not only the original chemical composition, but also the amount of such compounds being leached into the cellular medium. Cytotoxic effects of methacrylate monomers and oligomers have been previously reported in the literature. This is attributed to the induction of apoptosis, genotoxicity and cell cycle arrest. [46] Further work has speculated that such toxicity may also be related to the generation of reactive oxygen species (ROS) within cell cultures. [47] Structure toxicity relationships have also observed inverse correlation between cellular toxicity and compound lipophilicity, with the mechanism of these compounds likely membrane mediated. [48] This response can however be reduced, and/or ameliorated through solvent extraction prior to cellular interaction as reported in this work.
It is possible that specific machine parameters and/or forms of UV or possibly thermal post-curing might improve the degree of complete crosslinking in 3D printed parts, which might in turn reduce the leaching of cytotoxic compounds. This is particularly the case in SL where there are more parameters that could be easily varied. This further outlines the applicability of this polymer and favourability of LS when fabricating scaffolds for musculoskeletal tissue engineering applications. [28, 29, 33] Reductions observed in cellular viability were however completely ameliorated in C2C12 cells exposed 3D printed via LS as evidenced within this work is consolidated using a high-powered laser, requiring no additional chemical compounds to create 3D structures. This is opposed to the laser/UV lamp polymerisation of complex photo-polymers seen in SL and PolyJet. The solubility of PA-12 is also low. This results in surfaces of reduced chemical complexity and parts that do not contain small molecules to leach. Scaffolds for in vitro systems often comprise simplistic designs due to the rudimentary methods previously utilised. [29] The design flexibility afforded by LS provides the capability to rapidly produce, and reproduce multiple design iterations of such models. Although currently limited by the broad accessibility of this technology, recent developments have seen a trend toward commercialisation, with desktop LS printers becoming commercially accessible. [50] Enhanced polymer/process flexibility was observed when examining the chemical leachate of SL and PolyJet photo-polymers, with cell type specific responses evident. Despite reduced cellular responses to SL Clear-FL and PolyJet VeroClear resins in the direct condition, physiologically relevant morphological and transcriptional profiles were documented in leachate conditions. Such responses may present the opportunity to utilise these materials within devices in which cell/polymer interaction is confined to leachates within the culture medium. Pertinent to this are bespoke perfusion systems [7, 51] and microfluidic devices, [11] that are currently being utilised for the examination and recreation of musculoskeletal and neurological cellular physiological processes in vitro. [22, 52] The homogeneity of cytochrome P450 enzymatic activity across SL, LS and PolyJet AM processes, may also afford the opportunity to produce 3D printed fluidic devices that contain multiple cell types ( Table 2 ).
Table 2
Biocompatibility of 3D printed polymers. -Non-biocompatible; * supports proliferation; Ψ supports differentiation; # supports physiological Cytochrome P450 expression. Completely biocompatible, experiment specific compatibility, non-biocompatible.
Microfluidic systems concerned with the creation of 'organ on a chip' devices [22, 52, 53] often require intricate design features that necessitate photo-polymerisation processes such as SL and PolyJet. This is primarily due to consolidation variability of sintered particles within LS designs, often preventing the removal of un-sintered material from micron-sized features. [43] As such, although LS PA-12 provides bio-inert polymers for scaffolds necessitating cellular adherence, SL and PolyJet resins may be favoured for perfusion/screening devices dependent on cell line selection and desired phenotype.
Work has been undertaken where bespoke biocompatible SL resins have been synthesised, [54] however due to a lack of commercial availability, such research is currently limited in its translation to the wider scientific community. This further outlines the significance of readily available biocompatible AM Process
Direct Biocompatibility
Indirect Biocompatibility C2C12 SH-SY5Y HepG2 C2C12 SH-SY5Y HepG2 Stereolithography * --* Ψ Ψ # PolyJet photo-polymers elucidated within this work, specifically when aspiring to 3D print musculoskeletal, neurological and or pharmacological compatible systems.
Conclusions
This investigation observed cell type specific biocompatibility across three industry standard 3D
printing processes, which affords the opportunity for experiment-specific 3D printing process and polymer selection; dependent on desired biological application and necessitated design feature intricacy. To fully exploit AM technology within bioengineering systems, future work should seek to develop a broad range of compatibility data derived from commercially available and accessible 3D printing processes, across a diverse variety of mammalian cell types. Further work should also be undertaken to investigate the printing parameters and post-curing techniques of photo-polymerised resins. By manipulating these variables, it may be possible to further minimise the leaching of toxic compounds, with a view to also reducing the time required to reach biologically compatible levels.
